Back to Market Feed

KEVZARA 200 MG/1.14 ML PEN INJ

$2079.8200per ML

Strength

200 mg/1.14mL

Manufacturer

Sanofi-Aventis U.S. LLC

NDC

00024592201

Classification

Brand

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Last Updated

1/1/2026

Active Ingredients

Approval Type

Biologic (BLA)

FDA Application

On Market Since

5/22/2017

Pharmacological Classes

Interleukin 6 Receptor Antagonists

Interleukin-6 Receptor Antagonist

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+6.0%

1Y

+5.9%

3Y

N/A

5Y

N/A

All

+12.3%

Generic Alternatives

Save up to 1%

1 alternative • Same active ingredient

KEVZARA 200 MG/1.14 ML SYRINGE

00024591001•Sanofi-Aventis U.S. LLC

Related Drugs

Same classification

ACTEMRA 162 MG/0.9 ML SYRINGE

50242013801•Genentech, Inc.

ACTEMRA ACTPEN 162 MG/0.9 ML

50242014301•Genentech, Inc.